share_log

Needham Reiterates Buy on Vir Biotechnology, Maintains $19 Price Target

Needham Reiterates Buy on Vir Biotechnology, Maintains $19 Price Target

Needham重申买入vir biotechnology,维持$19的目标价
Benzinga ·  11/01 06:09  · 评级/大行评级

Needham analyst Joseph Stringer reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $19 price target.

Needham分析师Joseph Stringer重申vir biotechnology(纳斯达克:VIR)买入评级,维持19美元的目标价格。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发